diabetes and semaglutide Maximizing Semaglutide: Understanding the Doses for & Weight Loss Type 2 diabetes drug improves

Special Considerations for Different Patient Populations For Older Adults: Maintaining Independence Seniors need extra attention to muscle preservation during GLP-1 therapy

Your savings have been added to the cart

Participants starting with an average weight of 113kg achieved: 20.7% weight loss with the 7.2mg weekly regimen 17.5% weight loss with 2.4mg once weekly 2.4% weight loss with placebo More patients reached substantial weight loss milestones on the higher weekly dose

We view the shortage of GLP-1s to be much worse than the official data suggests

Liraglutide is injected daily compared to once weekly semaglutide (Wegovy and Ozempic) injections